HEL In Vitro Tumor Cell Target Expression Assay

This assay is to provide HEL-based In Vitro Tumor Cell Target Expression Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.

HEL

Human

A new human erythroleukemia cell line has been established. This line, designated HEL, is capable of spontaneous and induced globin synthesis, producing mainly Gγ and Aγ chains. Embryonic chains (ε, ζ) and α chains are detectable in very small amounts; β chains are undetectable. This line provides a new model system for studying aspects of erythroid cell differentiation and differential globin gene expression.

Erythroleukemia

Oncology

In Vitro Tumor Cell Target Expression Assay

HEL-cell based In Vitro Tumor Cell Target Expression Assay

Tumor Marker Expression Assay; Inhibitory Ligand Expression Assay

Tumor Cell Analysis Assay

Use FACS technology to analyze the tumor expression markers.